Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.0 was applied, updating from v3.4.3.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedStudy Documents now lists Revision 3.4.2 for the protocol and related documents, replacing Revision 3.4.1.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedAdditions include a glossary display toggle and new metadata items such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision: v3.3.4 now appears on the page, replacing v3.3.3, representing a backend/version update with no impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.